US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Vitamin D3 Injection

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1087-2018
Class II · Moderate risk Terminated

Dehydrated Alcohol Solution

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1086-2018
Class II · Moderate risk Terminated

Morphine Sulf inhalation

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1085-2018
Class II · Moderate risk Terminated

Pr/Pa/Ph

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1084-2018
Class II · Moderate risk Terminated

Triple P

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1083-2018
Class II · Moderate risk Terminated

Avastin 1.25 mg/0.05 mL prefilled syringe

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1082-2018
Class II · Moderate risk Terminated

DMSO 6.25% Opth Sol

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1081-2018
Class II · Moderate risk Terminated

Atropine 0.01% Opth Solution

Reason Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Ranier's Compounding Laboratory D-1080-2018
Class II · Moderate risk Terminated

Dymista

Reason Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

Mylan Pharmaceuticals Inc. NDC 0037-0245-23 D-1075-2018
Class II · Moderate risk Terminated

10 mg/mL Rocuronium Bromide

Reason CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

PharMEDium Services, LLC D-1045-2018
Class II · Moderate risk Terminated

5 mg/mL Ephedrine Sulfate

Reason CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

PharMEDium Services, LLC D-1044-2018
Class II · Moderate risk Terminated

10 mcg/mL Fentanyl Citrate

Reason CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

PharMEDium Services, LLC D-1043-2018
Class II · Moderate risk Terminated

Prednisolone Sodium Phosphate Oral Solution

Reason Defective Container: Tamper Evident foil seal not completely intact.

Morton Grove Pharmaceuticals, Inc. NDC 60432-212-08 D-1042-2018
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason Failed Dissolution Specifications:

West-Ward Columbus Inc NDC 0143-2112-05 D-1025-2018
Class II · Moderate risk Terminated

Doxycycline Hyclate Tablets

Reason Failed Dissolution Specifications:

West-Ward Columbus Inc NDC 0143-2112-50 D-1024-2018
Class I · High risk Terminated

Dr. King's Bronchial Care

Reason Microbial contamination

King Bio Inc. D-0977-2019